Study of new genes in head and neck cancer surgery tissue
Part of Cancer clinical trials.
This study looks at tissue from people having surgery for head and neck cancer at Stanford University. Researchers want to identify new proteins and genes that may help explain the cancer and guide future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are having surgery for head and neck cancer at Stanford University
- Your surgery must be at Stanford (not another hospital)
- You are willing to have the removed tissue used for research
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial collects tissue and health information to find the best treatment for your head and neck cancer. It may help guide your care by looking at the genetic details of your tumor.
This study collects tissue from people with newly diagnosed head and neck squamous cell cancer and grows “mini tumor models” in the lab. The goal is to see how these models respond to new therapies, which may help guide more effective treatment choices in the future.
This trial studies the role of epigenetic marks in head and neck cancer to improve diagnosis and treatment. If you have been newly diagnosed with head and neck squamous cell carcinoma and have not yet received treatment, you may be eligible to participate.
This study looks at “immune signals” in blood, saliva, and stool to learn more about head and neck cancers (especially squamous cell carcinoma). It may help researchers find patterns that improve understanding of disease or how treatment should be guided.
This study looks at whether certain blood tests can help predict how head and neck cancer will respond to treatment. If you are planning surgery for squamous cell cancer of the throat, voice box, or mouth, this trial may offer more information about your outlook.
This trial tries a more personalized treatment approach for people with locally advanced head and neck cancers by testing their tumor and blood for cancer “genetic” clues. If you may be eligible, you would have fresh tumor (and possibly lymph node) biopsies at the start and again if the cancer returns, plus blood tests to guide research and future study options.
Hear when a new Head and Neck Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.